Artwork

Third Wave에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Third Wave 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Evan Cole Lewis, M.D. - Peeking Into the Brain: How Psychedelics Are Redefining Neurology

1:10:39
 
공유
 

Manage episode 370917889 series 1354248
Third Wave에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Third Wave 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Dr. Evan Cole Lewis, VP of Psychedelic Neurology at Numinus, joins The Psychedelic Podcast to delve into the world of psychedelic neurology and its potential to revolutionize medicine.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-203-evan-cole-lewis-md/

Dr. Lewis & Paul F. Austin take us deeper into the underlying mechanisms of psychedelics and their impact on neurological networks. The conversation explores how psychedelics like MDMA, ketamine, psilocybin, and LSD can manipulate and reorganize those networks, leading to tailored treatment approaches for people with neurological conditions. From Dr. Lewis’s perspective, precision psychedelic medicine is poised to provide breakthrough treatments for traumatic brain injuries, concussions, functional seizures, cluster headaches, migraines, and mental illnesses.

With cautious optimism, Dr. Lewis and Paul envision a future where psychedelics offer transformative solutions for today’s most challenging conditions.

Evan Cole Lewis, M.D.:

Dr. Evan Cole Lewis is a neurologist and clinical neurophysiologist with expertise in pediatric neurology and epilepsy. He is an Assistant Professor with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto.

Dr. Lewis is the founder and medical director of the Neurology Centre of Toronto (NCT), Chief Medical Advisor for the Jamaican Medical Cannabis Corporation and VP of Psychedelic Neurology at Numinus, a Canadian company focused on research and therapeutics with psychedelic medicines.

Dr. Lewis has extensive clinical experience in the utilization of medical cannabis for the treatment of neurologic conditions in both adults and children. His practice focuses on brain network disorders, including concussion/persistent post-concussive symptoms, headache and migraine, and functional seizures.

He has a special interest in treating brain network disorders with psychedelic therapy. He has delivered many national and international educational seminars, talks, and lectures on brain network disorders, medical cannabis, psychedelic therapy, and the intersection of psychedelics and neurology.

Highlights:

  • Why Dr. Lewis chose to work at Numinus.
  • Exploring how psychedelics bridge the gap between psychiatry and neurology.
  • Why psychedelics challenge neurology to adopt a complex-systems approach.
  • How psychedelics counterbalance neural rigidity with harmony & flexibility.
  • Psychedelics’ potential to treat traumatic brain injuries (TBIs).
  • Ketamine’s role in activating & strengthening dormant neural pathways.
  • How plant medicine helps people unlearn old habits & experience child-like awareness.
  • The mystery of functional seizures.
  • Dr. Lewis’ belief that psychedelics will enhance neuroscience & precision medicine.

Key Links:

Episode Sponsor:

  continue reading

332 에피소드

Artwork
icon공유
 
Manage episode 370917889 series 1354248
Third Wave에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Third Wave 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Dr. Evan Cole Lewis, VP of Psychedelic Neurology at Numinus, joins The Psychedelic Podcast to delve into the world of psychedelic neurology and its potential to revolutionize medicine.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-203-evan-cole-lewis-md/

Dr. Lewis & Paul F. Austin take us deeper into the underlying mechanisms of psychedelics and their impact on neurological networks. The conversation explores how psychedelics like MDMA, ketamine, psilocybin, and LSD can manipulate and reorganize those networks, leading to tailored treatment approaches for people with neurological conditions. From Dr. Lewis’s perspective, precision psychedelic medicine is poised to provide breakthrough treatments for traumatic brain injuries, concussions, functional seizures, cluster headaches, migraines, and mental illnesses.

With cautious optimism, Dr. Lewis and Paul envision a future where psychedelics offer transformative solutions for today’s most challenging conditions.

Evan Cole Lewis, M.D.:

Dr. Evan Cole Lewis is a neurologist and clinical neurophysiologist with expertise in pediatric neurology and epilepsy. He is an Assistant Professor with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto.

Dr. Lewis is the founder and medical director of the Neurology Centre of Toronto (NCT), Chief Medical Advisor for the Jamaican Medical Cannabis Corporation and VP of Psychedelic Neurology at Numinus, a Canadian company focused on research and therapeutics with psychedelic medicines.

Dr. Lewis has extensive clinical experience in the utilization of medical cannabis for the treatment of neurologic conditions in both adults and children. His practice focuses on brain network disorders, including concussion/persistent post-concussive symptoms, headache and migraine, and functional seizures.

He has a special interest in treating brain network disorders with psychedelic therapy. He has delivered many national and international educational seminars, talks, and lectures on brain network disorders, medical cannabis, psychedelic therapy, and the intersection of psychedelics and neurology.

Highlights:

  • Why Dr. Lewis chose to work at Numinus.
  • Exploring how psychedelics bridge the gap between psychiatry and neurology.
  • Why psychedelics challenge neurology to adopt a complex-systems approach.
  • How psychedelics counterbalance neural rigidity with harmony & flexibility.
  • Psychedelics’ potential to treat traumatic brain injuries (TBIs).
  • Ketamine’s role in activating & strengthening dormant neural pathways.
  • How plant medicine helps people unlearn old habits & experience child-like awareness.
  • The mystery of functional seizures.
  • Dr. Lewis’ belief that psychedelics will enhance neuroscience & precision medicine.

Key Links:

Episode Sponsor:

  continue reading

332 에피소드

모든 에피소드

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드

탐색하는 동안 이 프로그램을 들어보세요.
재생